61 TREATMENT WITH SOFOSBUVIR + RIBAVIRIN FOR 12 WEEKS ACHIEVES SVR12 OF 78% IN GT2/3 INTERFERON-INELIGIBLE, -INTOLERANT, OR -UNWILLING PATIENTS: RESULTS OF THE PHASE 3 POSITRON TRIAL

Saved in:
Bibliographic Details
Published in:Journal of hepatology 2013-04, Vol.58, p.S28-S28
Main Authors: Jacobson, I, Yoshida, E.M, Sulkowski, M, Nelson, D.R, Svarovskaia, E, An, D, McNally, J, Brainard, D.M, Symonds, W.T, McHutchison, J.G, Pianko, S, Kowdley, K.V
Format: Article
Language:English
Subjects:
Gastroenterology and Hepatology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0168-8278
1600-0641
DOI:10.1016/S0168-8278(13)60063-X